Pricing
Get started
Sign InGet started
Email gallery/MacroFactor/Contribute to MacroFactor algorithm improvements (training density and menstrual cycle weight fluctuations)
MacroFactor logoMacroFactor

Contribute to MacroFactor algorithm improvements (training density and menstrual cycle weight fluctuations)

Contribute to MacroFactor algorithm improvements (training density and menstrual cycle weight fluctuations) email from MacroFactor screenshot

Make this email yours with Migma AI

Type your website. Migma AI designs one like it with your logo, colors, and images.

This email
→
Your brand
Your logo

About this email

Captured October 27, 2026·Announcement

MacroFactor requests user feedback through two short research surveys to help refine training volume and menstrual cycle weight trend algorithms.

Single-column minimalist layout with a black header logo bar, clean typography-driven content sections with bold headers, text-link CTAs, and a simple legal footer.

Explore similar emails

  • Light Mode
  • Minimalist
  • Text Heavy
  • Single Column
  • Health, Fitness & Wellness
  • Retention
  • App Users
  • Feedback And Survey And Poll

Color palette

Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.

Solutions

  • Marketers
  • Designers
  • Developers
  • Enterprise

Resources

  • Countdowns
    New
  • Email gallery
  • Pricing
  • Docs
  • Blog

Company

  • About Us
  • Brand guidelines
  • Brand kit
  • Careers
  • Support
  • FAQ

Legal

  • Privacy Policy
  • Terms & Conditions
  • Do not sell or share my personal information
  • Copyright Notice & Takedown
  • Data Processing Agreement
  • Acceptable Use

Socials

  • X / Twitter
  • Discord
  • YouTube
  • LinkedIn
MigmaAI
© 2026 MigmaAI, Inc. All rights reserved.
Backed byEWOR Logo DarkEWOR Logo Light
Built with ❤️ in Stockholm & Barcelona

More emails like this

Explore other emails with shared design, campaign, or industry tags.

Every needs your help email from Every
Every logoEvery

Every needs your help

Create this for my brand
Answer this question for us. email from Pair of Thieves
Pair of Thieves logoPair of Thieves

Answer this question for us.

Create this for my brand
Let's get to know you email from Mountain Joe's
Mountain Joe's logoMountain Joe's

Let's get to know you

Create this for my brand
HTTP2Shell Brotli Vulnerability 🚨, PwC 590GB data theft 💼, Tailscale SSH Root Flaw 🐛 email from TLDR Cybersecurity
TLDR Cybersecurity logoTLDR Cybersecurity

HTTP2Shell Brotli Vulnerability 🚨, PwC 590GB data theft 💼, Tailscale SSH Root Flaw 🐛

Create this for my brand
Anthropic Versus Anthropic email from Zvi Mowshowitz
ZMZvi Mowshowitz

Anthropic Versus Anthropic

Create this for my brand
Quick check-in email from Vitalbloom Inc
Vitalbloom Inc logoVitalbloom Inc

Quick check-in

Create this for my brand
First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication email from Takeda Pharmaceutical
TPTakeda Pharmaceutical

First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication

Create this for my brand
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1 email from Takeda Pharmaceutical
TPTakeda Pharmaceutical

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

Create this for my brand